Feung’s research interests evolve around using cancer genomics to unravel the heterogeneity in breast cancer to improve patient management.
June 16, 2020
Feung’s research interests evolve around using cancer genomics to unravel the heterogeneity in breast cancer to improve patient management.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
